AbbVie Inc (ABBV)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	4,278,000	5,122,000	5,339,000	5,993,000	4,863,000	6,514,000	8,685,000	7,585,000	11,836,000	13,407,000	12,637,000	12,479,000	11,542,000	7,534,000	6,663,000	5,159,000	4,616,000	7,381,000	6,957,000	8,436,000
Revenue (ttm)	US$ in thousands	56,334,000	55,533,000	55,000,000	54,403,000	54,318,000	55,138,000	56,023,000	56,741,000	58,054,000	57,819,000	57,349,000	56,725,000	56,197,000	55,169,000	53,729,000	50,195,000	45,804,000	40,650,000	36,227,000	34,057,000
Net profit margin		7.59%	9.22%	9.71%	11.02%	8.95%	11.81%	15.50%	13.37%	20.39%	23.19%	22.04%	22.00%	20.54%	13.66%	12.40%	10.28%	10.08%	18.16%	19.20%	24.77%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $4,278,000K ÷ $56,334,000K
= 7.59%

AbbVie Inc's net profit margin has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. Starting at a relatively high point of 24.77% in March 2020, the net profit margin decreased to 10.08% by December 2020. Subsequently, there was a gradual improvement in the net profit margin, with figures ranging between 10.28% to 23.19% until September 2022.

However, there was some variability in the net profit margin from March 31, 2023, onwards, with the margin declining to 7.59% by December 31, 2024. Overall, AbbVie Inc's net profit margin has experienced both peaks and troughs throughout this period, indicating fluctuations in profitability. Further analysis would be needed to understand the reasons behind these fluctuations and their impact on the company's financial performance.